OBJECTIVE: To assess the patterns of regression of renal angiomyolipoma (AML) post embolisation and report the outcomes related to the use of different embolic materials. METHODS: A retrospective review of all patients who underwent embolisation for renal AML at our institution between January 2004 and April 2012. RESULTS: 13 patients underwent 16 episodes of embolisation. Coils were used as the primary embolisation material in 10 episodes and microspheres in 6 episodes. The size reduction rate highly correlated on CT follow-up between the two groups, with 25.6% vs 22.7% reduction at 12 months, 27.5% vs 25.1% at 24 months, 35.0% vs 33.0% at 36 months and 35.0% vs 36.8% at 48 months. During follow-up, all tumours reduced in size with one patient requiring subsequent embolisation whose tumour reduced by only 6.5% after 1 year and subsequently exhibited regrowth after 4 years. Two patients presented with rebleeding and underwent repeat embolisation. Our overall retreatment rate (23%) is well within the literature range (up to 37%). None of the patients underwent surgery. CONCLUSION: The majority of AML shrinkage occurs within the first year following embolisation and appears to plateau after 3 years, which could have an impact on follow-up strategy. The percentage reduction at 1 year may reflect the long-term effect of embolisation with tumours demonstrating minor size reduction more likely to relapse at long-term follow-up. Embolisation of renal AML produces durable long-term results regardless of the choice of embolic agent. ADVANCES IN KNOWLEDGE: These findings provide information to guide CT follow-up of renal AML post embolisation.
OBJECTIVE: To assess the patterns of regression of renal angiomyolipoma (AML) post embolisation and report the outcomes related to the use of different embolic materials. METHODS: A retrospective review of all patients who underwent embolisation for renal AML at our institution between January 2004 and April 2012. RESULTS: 13 patients underwent 16 episodes of embolisation. Coils were used as the primary embolisation material in 10 episodes and microspheres in 6 episodes. The size reduction rate highly correlated on CT follow-up between the two groups, with 25.6% vs 22.7% reduction at 12 months, 27.5% vs 25.1% at 24 months, 35.0% vs 33.0% at 36 months and 35.0% vs 36.8% at 48 months. During follow-up, all tumours reduced in size with one patient requiring subsequent embolisation whose tumour reduced by only 6.5% after 1 year and subsequently exhibited regrowth after 4 years. Two patients presented with rebleeding and underwent repeat embolisation. Our overall retreatment rate (23%) is well within the literature range (up to 37%). None of the patients underwent surgery. CONCLUSION: The majority of AML shrinkage occurs within the first year following embolisation and appears to plateau after 3 years, which could have an impact on follow-up strategy. The percentage reduction at 1 year may reflect the long-term effect of embolisation with tumours demonstrating minor size reduction more likely to relapse at long-term follow-up. Embolisation of renal AML produces durable long-term results regardless of the choice of embolic agent. ADVANCES IN KNOWLEDGE: These findings provide information to guide CT follow-up of renal AML post embolisation.
Authors: David H Ewalt; Norman Diamond; Chet Rees; Steven P Sparagana; Mauricio Delgado; Lori Batchelor; E Steve Roach Journal: J Urol Date: 2005-11 Impact factor: 7.450
Authors: Uri Rimon; Mordechai Duvdevani; Alexander Garniek; Gil Golan; Paul Bensaid; Jacob Ramon; Benyamina Morag Journal: AJR Am J Roentgenol Date: 2006-09 Impact factor: 3.959
Authors: Nishita Kothary; Michael C Soulen; Timothy W I Clark; A J Wein; Richard D Shlansky-Goldberg; Peter B Crino; S William Stavropoulos Journal: J Vasc Interv Radiol Date: 2005-01 Impact factor: 3.464
Authors: Jacob Ramon; Uri Rimon; Alex Garniek; Gil Golan; Paul Bensaid; Noam D Kitrey; Andrei Nadu; Zohar A Dotan Journal: Eur Urol Date: 2008-04-18 Impact factor: 20.096
Authors: Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy Journal: Quant Imaging Med Surg Date: 2017-02
Authors: A Hocquelet; F Cornelis; Y Le Bras; M Meyer; E Tricaud; A S Lasserre; J M Ferrière; G Robert; N Grenier Journal: Eur Radiol Date: 2014-06-03 Impact factor: 5.315